首页    期刊浏览 2025年02月27日 星期四
登录注册

文章基本信息

  • 标题:Facial vein injection of human cells in severe combined immunodeficiency (SCID) neonatal mice
  • 本地全文:下载
  • 作者:Nimshitha Pavathuparambil Abdul Manaph ; Mohammed Al-Hawwas ; Liang Liu
  • 期刊名称:MethodsX
  • 印刷版ISSN:2215-0161
  • 电子版ISSN:2215-0161
  • 出版年度:2018
  • 卷号:5
  • 页码:1281-1286
  • DOI:10.1016/j.mex.2018.10.006
  • 语种:English
  • 出版社:Elsevier
  • 摘要:Graphical abstractDisplay OmittedHighlights•Precise intravenous injection of human or mice stem cells in immunocompromised neonates.•Fastest method of facial vein injection with confirmation of the procedure success.•Direct method of stem cell delivery in neonatal brain, heart and liver.AbstractIntravenous injection is a standard procedure for delivering human stem cells and therapeutic agents. Currently, genetically modified severe combined immunodeficiency (SCID) mice are used for engraftment studies using human cells. SCID neonates have better integration and survivability of human cells compared to adult SCID mice, as their immune system will not be developed in the first few days after birth. However, intravenous injections in neonates are difficult. This protocol describes a reliable and reproducible method for injecting cells into the facial vein of P3/P4 (3 or 4 days post-birth) SCID neonates to study their engraftment. The injection was safe and well tolerated by the pups. Post-injection analysis revealed the distribution of tagged cells in different organs. Results suggest that this new method can serve as a pre-analysis for transplantation studies using human stem cells beforein vivoanimal model testing.
  • 关键词:Neonates;Facial vein;Intravenous injection;Stem cells;Delivery
国家哲学社会科学文献中心版权所有